A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells

European Journal of Pharmacology

Volumn 657, Issue 1-3, 2011, Pages 4-9

  Kars, Meltem Demirel ^a,b   Işeri, Özlem Darcansoy ^c   Gündüz, Ufuk ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

Author keywords

MCF 7; Microarray analysis; Multiple drug resistance; Paclitaxel; Vincristine

Indexed keywords

BETA TUBULIN; GLUTATHIONE TRANSFERASE P1; PACLITAXEL; VINCRISTINE;

ABCB4 GENE; ARTICLE; CANCER RESISTANCE; CCNA2 GENE; CCNE2 GENE; CDKN2A GENE; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; FGFR1 GENE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MAP1A GENE; MDR1 GENE; MICROARRAY ANALYSIS; MICROTUBULE ASSEMBLY; MULTIDRUG RESISTANCE; PDCD2 GENE; PDCD4 GENE; PDCD6 GENE; PDCD8 GENE; PHARMACOGENOMICS; PRIORITY JOURNAL; TNFRSF9 GENE; TTBK2 GENE; UPREGULATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; REPRODUCIBILITY OF RESULTS; VINCRISTINE;

EID: 79952486684     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.02.001     Document Type: Article

References (50)

1. S. Akura, T. Taga, and T. Kishimoto Interleukin-6 in biology and medicine Adv. Immunol. 54 1993 1 78 (Pubitemid 23289250)
2. R. Anjum, P.P. Roux, B.A. Ballif, S.P. Gygi, and J. Blenis The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling Curr. Biol. 15 2005 1762 1767 (Pubitemid 41415634)
3. H.K. Berrieman, M.J. Lind, and L. Cawkwell Do β tubulin mutations have a role in resistance to chemotherapy? Lancet Oncol. 5 2004 158 164 (Pubitemid 38262847)
4. A.R. Black, J.D. Black, and J. Azizkhan-Clifford Sp1 and Kruppellike factor family of transcription factors in cell growth regulation and cancer J. Cell Physiol. 188 2001 143 160 (Pubitemid 32622905)
5. J.Y. Blay, S. Negrier, V. Combaret, S. Attali, E. Goillot, Y. Merrouche, A. Mercatello, A. Ravault, J.M. Tourani, J.F. Moskovtchenko, T. Philip, and M. Favrot Serum level of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma Cancer Res. 52 1992 3317 3322
6. T.D. Boyer The glutathione S-transferases: an update Hepatology 9 1989 486 496 (Pubitemid 19074986)
7. H.J. Broxterman, G. Giaccone, and J. Lankelma Multidrug resistance proteins and other drug transport-related resistance to natural product agents Curr. Opin. Oncol. 7 1995 532 540
8. C.S. Cheng, D. Luo, and Y. Xie Taxol induced Bcl-2, protein phosphorylation in human hepatocellular carcinoma QGY-7703 cell line Cell Biol. Int. 25 2001 261 265 (Pubitemid 32553014)
9. A.M. Chinnaiyan The apoptosome: heart and soul of the cell death machine Neoplasia 1 1999 5 15
10. S.P. Cole, and R.G. Deeley Multidrug resistance associated with overexpression of MRP Cancer Treat. Res. 87 1996 39 62
11. K.T. Douglas Mechanism of action of glutathione-dependent enzymes Adv. Enzymol. Relat. Areas Mol. Biol. 59 1987 103 116
12. S. Drukman, and M. Kavallaris Microtubule alterations and resistance to tubulin-binding agents (Review) Int. J. Oncol. 21 2002 621 628
13. Z. Duan, A.J. Feller, R.T. Penson, B.A. Chabner, and M.V. Seiden Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of IL-6, IL-8 and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype Clin. Cancer Res. 5 1999 3445 3453
14. M. Filipits, R.W. Suchomel, G. Dekan, K. Haider, G. Valdimarsson, D. Depisch, and R. Pirker MRP and MDR1 gene expression in primary breast carcinomas Clin. Cancer Res. 2 1996 1231 1237 (Pubitemid 26238456)
15. P.A. Fitzpatric, and R. Wheeler The immunopharmacology of Paclitaxel (Taxol), docetaxel (Taxotere) and related agents Int. Immunopharmacol. 3 2003 1699 1714 (Pubitemid 37421260)
16. P. Giannakakou, D.L. Sackett, Y.K. Kang, Z. Zhan, J.T. Buters, T. Fojo, and M.S. Poruchynsky Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization J. Biol. Chem. 272 1997 17118 17125 (Pubitemid 27289821)
17. P.M. Gilmore, N. McCabe, J.E. Quinn, R.D. Kennedy, J.J. Gorski, H.N. Andrews, S. McWilliams, M. Carty, P.B. Mullan, W.P. Duprex, E.T. Liu, P.G. Johnston, and D.P. Harkin BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3 Cancer Res. 64 2004 4148 4154 (Pubitemid 38802417)
18. M. Hari, H. Yang, C. Zeng, M. Canizales, and F. Cabral Expression of class III β-tubulin reduces microtubule assembly and confers resistance to paclitaxel Cell Motil. Cytoskel 56 2003 45 56 (Pubitemid 37059485)
19. S. Hasegawa, Y. Miyoshi, C. Egawa, M. Ishitobi, Y. Tamaki, M. Monden, and S. Noguchi Mutational analysis of the class I beta-tubulin gene in human breast cancer Int. J. Cancer 101 2002 46 51 (Pubitemid 34832996)
20. L.A. Hazlehurst, T.H. Landowski, and W.S. Dalton Role of the tumor microenvironment in mediating denovo resistance to drugs and physiological mediators of cell death Oncogene 22 2003 7396 7402 (Pubitemid 37487165)
21. S. Honore, E. Pasquier, and D. Braguer Understanding microtubule dynamics for improved cancer therapy Cell. Mol. Life Sci. 62 2005 3039 3056 (Pubitemid 43004753)
22. W. Hu, and J.J. Kavanagh Anticancer therapy targeting the apoptotic pathway Lancet Oncol. 4 2003 721 729 (Pubitemid 37527207)
23. O.D. Işeri, M.D. Kars, S. Eroǧlu, and U. Gündüz Drug resistant MCF-7 Cell lines also developed cross-resistance to structurally unrelated anticancer agents Int. J. Hema. Oncol. 19 2009 1 8
24. O.D. Işeri, M.D. Kars, F. Arpaci, and U. Gündüz Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins Cancer Chemother. Pharmacol. 65 2010 447 455
25. R.U. Janicke, M.L. Sprengart, and A.G. Porter Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis J. Biol. Chem. 273 1998 9357 9360 (Pubitemid 28183012)
26. A.J. Jensen, A.E. Lykkesfeldt, J. Worm, U. Ralfkiaer, U. Espelund, and J.S. Jepsen Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator Growth Horm. IGF Res. 16 2006 224 239 (Pubitemid 44296071)
27. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat. Rev. Cancer 4 2004 253 265 (Pubitemid 38525281)
28. M.D. Kars, O.D. Işeri, U. Gunduz, and J. Molnar Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines Chemotherapy 54 2008 194 200 (Pubitemid 351929270)
29. M.D. Kars, O.D. Işeri, and U. Gündüz Drug resistant breast cancer cells overexpress ETS1 gene Biomed. Pharmacother. 64 2010 458 467
30. M.D. Kars, O.D. Iseri, U. Gunduz, A.U. Ural, F. Arpaci, and J. Molnar Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds Anticancer Res. 26 2006 4559 4568 (Pubitemid 46031531)
31. M.D. Kars, Ö.D. Işeri, A.U. Ural, F. Avcu, M. Beyzadeoǧlu, B. Dirican, and U. Gündüz Development of radioresistance in drug resistant human MCF-7 breast cancer cells J. Radioter. Pract. 8 2009 207 213
32. A. Konig, T. Menzel, S. Lynen, L. Wrazel, A. Rosén, A. Al-Katib, E. Raveche, and J.L. Gabrilove Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis Leukemia 11 1997 258 265 (Pubitemid 27085171)
33. H. Lage Drug resistance in breast cancer Cancer Ther. 1 2003 81 91
34. J.H. Lee, S.B. Rho, and T. Chun Programmed cell death 6 (PDCD6) protein interacts with death-associated protein kinase 1 (DAPk1): additive effect on apoptosis via caspase-3 dependent pathway Biotech. Lett. 27 2005 1011 1015 (Pubitemid 41215874)
35. Z.W. Li, and W.S. Dalton Tumor microenvironment and drug resistance in hematologic malignancies Blood Rev. 20 2006 333 342 (Pubitemid 44691998)
36. Y. Liu, H. Peng, and J.T. Zhang Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using amp array Mol. Pharmacol. 68 2005 430 438 (Pubitemid 41058306)
37. B.T. McGrogan, B. Gilmartin, D.N. Carney, and A. McCann Taxanes, microtubules and chemoresistant breast cancer Biochim. Biophys. Acta 1785 2008 96 132
38. E. Mechetner, A. Kyshtoobayeva, S. Zonis, H. Kim, R. Stroup, R. Garcia, R.J. Parker, and J. Freuhauf Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in-vitro resistance to Taxol and Doxorubicin Clin. Cancer Res. 4 1998 389 398 (Pubitemid 28122754)
39. T. Menzel, Z. Rahman, E. Calleja, K. White, E.L. Wilson, R. Wieder, and J. Gabrilove Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine Blood 87 1996 1056 1063 (Pubitemid 26043533)
40. P.B. Mullan, J.J. Gorski, and P. Harkin BRCA1-a good predictive marker of drug sensitivity in breast cancer treatment? Biochim. Biophys. Acta 1766 2006 205 216
41. P.B. Mullan, J.E. Quinn, P.M. Gilmore, S. McWilliams, H. Andrews, C. Gervin, N. McCabe, S. McKenna, P. White, Y.H. Song, S. Maheswaran, E. Liu, D.A. Haber, P.G. Johnston, and D.P. Harkin BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents Oncogene 20 2001 6123 6131 (Pubitemid 32964424)
42. M. Murphy, A. Hinman, and A.J. Levine Wild-type p53 negatively regulates the expression of a microtubule-associated protein Genes Dev. 10 1996 2971 2980 (Pubitemid 26412524)
43. C. O'Loughlin, M. Heenan, S. Coyle, and M. Clynes Altered cell cycle response of drug resistant lung carcinoma cells to doxorubicin Eur. J. Cancer 36 2000 1149 1160 (Pubitemid 30330914)
44. S.J. Park, C.H. Wu, M.R. Choi, F. Najafi, A. Emami, and A.R. Safa P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5 Biochem. Pharmacol. 72 2006 293 307 (Pubitemid 43975081)
45. R. Rouzier, R. Rajan, P. Wagner, K.R. Hess, D.L. Gold, and J. Stec Microtubule associated protein tau: a marker of paclitaxel sensitivity in breast cancer Proc. Natl Acad. Sci. USA 102 2005 8315 8320 (Pubitemid 40800086)
46. M. Sabbah, S. Emamia, G. Redeuilh, S. Julien, G. Prévost, A. Zimber, R. Ouelaa, M. Bracke, O. De Wever, and C. Gespach Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers Drug Resist. Update 11 2008 123 151
47. S.C. Shih, and K.P. Claffey Role of AP-1 and HIF-1 transcription factors in TGF-b activation of VEGF expression Growth Factors 19 2001 19 34 (Pubitemid 32970678)
48. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171 182 (Pubitemid 34161138)
49. C.C. Zhang, J.M. Yang, E. White, M. Murphy, A. Levine, and W.N. Hait The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells Oncogene 16 1998 1617 1624 (Pubitemid 28159910)
50. G.J. Zhang, and I. Adachi Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma Anticancer Res. 19 1999 1427 1432 (Pubitemid 29257471)